Himalaya Technologies Inc (HMLA)

[al19]

I am liking the Float here, 8 K filed last week .


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549



FORM 8-K



CURRENT REPORT



Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): May 26, 2022



HIMALAYA TECHNOLOGIES, INC.

(Exact name of Registrant as specified in its Charter)



NEVADA 000-55282 26-0841675
(State or other jurisdiction

of incorporation)


(Commission

File No.)


(IRS Employer

Identification No.)



1 E Erie St, Ste 525 Unit #2420, Chicago, IL 60611

(Address of principal executive offices)



[phone]

(Registrant’s Telephone Number)





(Former name or address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):



? Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:



Title of each class Trading symbol(s) Name of each exchange on which registered
Common HMLA OTC Pink


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2) ?



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ?










FOMO CORP. is referred to herein as “FOMO”, “the Company”, “we”, or “us”.



Item 7.01 Regulation FD Disclosure.



We are hereby filing a presentation deck for our 19.9% minority investment GenBio, Inc. (https://genbioinc.com/).



Item 9.01. Exhibits



(a) Exhibits. The following exhibits are filed with this Current Report on Form 8-K:



Exhibit No. Description
10.1 GenBio, Inc. Presentation Deck – Spring 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)